Pharmaceutical compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9056140
APP PUB NO 20100286062A1
SERIAL NO

12677701

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a compound comprising:

    (a) a first component capable of binding to ER+ cell receptors; and(b) a second component;wherein the second component is a ribosome inactivating toxin and is conjugated to the first component.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOCOPEA LIMITEDCENTRAL POINT 45 BEECH STREET LONDON EC2Y 8AD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caparros-Wanderley, Wilson Romero Aylesbury, GB 17 120
Stoloff, Gregory Alan London, GB 26 608

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 16, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00